TrialFrontiers in endocrinology2022

Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial.

Rebecca Brandon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.